2020
DOI: 10.1111/1759-7714.13623
|View full text |Cite
|
Sign up to set email alerts
|

Successful use of extracorporeal membrane oxygenation for airway‐obstructing lung adenocarcinoma

Abstract: Endobronchial-invasive lung cancers are generally diagnosed at advanced stages and may require emergency treatment for airway obstruction. Stent implantation is a common intervention for such obstructed airways but certain subsets of patients cannot receive adequate treatment without respiratory support. Venovenous extracorporeal membrane oxygenation (ECMO) is a salvage therapy for respiratory failure but its usefulness in managing patients with advanced lung cancer remains unclear given the poor prognosis. In… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 13 publications
0
12
0
Order By: Relevance
“…Interestingly, 365‐day mortality due to cancer was highest in the other diagnoses group (36.7%), suggesting that many cancer patients received ECMO support during cancer treatment. Cancer often causes unpredictable cardiac or respiratory failure during treatment, which requires temporary ECMO support 25,26 . In particular, there are reports that ECMO support may be a useful treatment option for patients with lung cancer or hematologic malignancies 25–27 .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Interestingly, 365‐day mortality due to cancer was highest in the other diagnoses group (36.7%), suggesting that many cancer patients received ECMO support during cancer treatment. Cancer often causes unpredictable cardiac or respiratory failure during treatment, which requires temporary ECMO support 25,26 . In particular, there are reports that ECMO support may be a useful treatment option for patients with lung cancer or hematologic malignancies 25–27 .…”
Section: Discussionmentioning
confidence: 99%
“…25,26 In particular, there are reports that ECMO support may be a useful treatment option for patients with lung cancer or hematologic malignancies. [25][26][27] Clinical indications for ECMO support are increasing based on recent research. ECMO is frequently implemented for high-risk patients who have undergone cardiac ablation or complex tracheobronchial and lung surgery in the operating theater.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are only rare reports of ECMO used in combination with either the airway tumor debulking or stent placement, but our patient was able to undergo both procedures while on VV ECMO with favorable outcomes. Furthermore, there has been one additional case that also reported success with a similar treatment strategy for an airway obstructing lung cancer [ 17 ]. This finding is encouraging as there are currently few treatment options for patients with severe tracheal obstructions secondary to tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, if it is predicted that hemodynamic instability or respiratory failure may occur during surgery, it is possible to avoid adding ECMO in emergency situations; this would reduce the mortality rate in such situations. Therefore, ECMO may be useful in patients with hemodynamic instability (large mediastinal tumors compressing the heart and great vessels [ 20 ], tumors requiring complex pulmonary resection [ 21 ], or trauma with massive bleeding [ 17 ]) or respiratory failure (large mediastinal mass or pulmonary neoplasm compressing the airways [ 22 ], trachea-bronchial surgery with carinal resection [ 23 ]) during surgery.…”
Section: Discussionmentioning
confidence: 99%